Sign in
4

Changes in Ownership

CG Oncology, Inc. Filed Acc 0001684531-26-000002

Director sold 1,964 shares at $60.12 ($118,076)

  • Director acquired 1,964 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mulay James · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Exercise or conversion : show line 1 in the form 10b5-1 +654 $3.72 $2,433 654 D
2026-06-15 Sale : show line 2 in the form 10b5-1 −654 $60.12 $39,318 0 D
2026-06-15 Exercise or conversion : show line 3 in the form 10b5-1 +1,310 $12.59 $16,493 1,310 D
2026-06-15 Sale : show line 4 in the form 10b5-1 −1,310 $60.12 $78,757 0 D
Open-market sales · 1,964 sh · avg $60.12 · $118,076

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-15 Exercise or conversion : show line 5 in the form 10b5-1 Director Stock Option (right to buy) −654 0 D
2026-06-15 Exercise or conversion : show line 6 in the form 10b5-1 Director Stock Option (right to buy) −1,310 2,620 D
Loading xslF345X06/form4-06162026_090604.xml…